Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: A population-based register study

European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
Poul JennumJakob Kjellberg

Abstract

We aimed to evaluate all-cause mortality of middle-aged and elderly subjects diagnosed with dementia and treated with psychotropic drugs as compared with controls subjects. Using data from the Danish National Patient Registry, n=26,821 adults with a diagnosis of dementia were included. They were compared with 44,286 control subjects with a minimum follow-up of four years and matched on age, gender, marital status, and community location. Information about psychotropic medication use (benzodiazepines, antidepressants, antipsychotics) was obtained from the Danish Medicinal Product Statistics. All-cause mortality was higher in patients with dementia as compared to control subjects. Mortality hazard ratios were increased for subjects prescribed serotonergic antidepressant drugs (respectively, HR=1.355 (SD=0.023), P=0.001 in patients; HR=1.808 (0.033), P<0.001 in controls), tricyclic antidepressants (HR=1.004 (0.046), P=0.925; HR=1.406 (0.061), P<0.001), benzodiazepines (HR=1.131 (0.039), P=0.060); HR=1.362 (0.028), P<0.001), benzodiazepine-like drugs (HR=1.108 (0.031), P=0.078; HR=1.564 (0.037, P<0.001), first-generation antipsychotics (HR=1.183 (0.074), P=0.022; HR=2.026 (0.114), P<0.001), and second-generation antipsychotics (HR=...Continue Reading

References

May 16, 1998·Biological Psychiatry·D F KripkeL Garfinkel
Mar 3, 2001·Scandinavian Journal of Public Health·J MerloA Melander
May 7, 2002·Journal of Toxicology. Clinical Toxicology·Papa N GueyeFrédéric J Baud
Jun 11, 2003·Neurology·S A FactorUNKNOWN Parkinson Study Group
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Dec 2, 2005·The New England Journal of Medicine·Philip S WangM Alan Brookhart
Dec 15, 2005·Neuroepidemiology·R S WilsonD A Evans
Jul 20, 2006·The Journal of Clinical Psychiatry·Ludmila A KryzhanovskayaPatrizia A Cavazzoni
Sep 14, 2007·Kidney International·W C WinkelmayerP S Wang
Sep 28, 2007·The American Journal of Psychiatry·Helen C KalesFrederic C Blow
Mar 10, 2009·Sleep Medicine·Daniel F Kripke
Mar 10, 2009·Sleep Medicine·Lena MallonJerker Hetta
Mar 24, 2009·Current Neuropharmacology·Rosa LiperotiAndrea Corsonello
Jun 24, 2009·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Chi-Shin WuKeh-Ming Lin
May 17, 2011·The American Journal of Psychiatry·Cheryl L P VigenLon S Schneider
Sep 17, 2011·European Heart Journal·Jussi HonkolaHeikki V Huikuri
Dec 24, 2011·The American Journal of Psychiatry·Helen C KalesFrederic C Blow
Jan 26, 2012·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Connie MarrasPaula A Rochon
Mar 1, 2012·BMJ Open·Daniel F KripkeLawrence E Kline
Apr 3, 2012·Journal of Geriatric Psychiatry and Neurology·Sachin BhaleraoHelen C Kales
Oct 31, 2012·Acta Psychiatrica Scandinavica·Lone BaandrupBirte Glenthoj
Mar 5, 2013·The Medical Journal of Australia·Angela C RintoulOlaf H Drummer

❮ Previous
Next ❯

Citations

Apr 20, 2016·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·Andrea TicinesiTiziana Meschi
Mar 24, 2017·Brain : a Journal of Neurology·Suzanne ReevesRobert Howard
May 27, 2017·BMC Pharmacology & Toxicology·Jon BrännströmYngve Gustafson
Sep 7, 2017·Journal of Sleep Research·Dieter RiemannKai Spiegelhalder
Nov 17, 2017·International Journal of Geriatric Psychiatry·Laura SaarelainenHeidi Taipale
Feb 6, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·A EgebergU Mrowietz
Mar 13, 2020·The British Journal of Dermatology·H YenC-C Chi
Mar 7, 2018·Reviews in the Neurosciences·Man AmanatNima Rezaei
Feb 10, 2019·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·I J A de BruinF de Vries
Oct 15, 2020·Psychological Medicine·Robert Whitaker
Jun 18, 2021·Evidence-based Complementary and Alternative Medicine : ECAM·Yan-Hua LinYong-Mei Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here